Literature DB >> 19521278

Automated in situ hybridization and immunohistochemistry for cytomegalovirus detection in paraffin-embedded tissue sections.

David Y Lu1, Jing Qian, Kirk A Easley, Sandra M Waldrop, Cynthia Cohen.   

Abstract

Cytomegalovirus (CMV) infections cause serious morbidity and mortality in immunocompromised individuals. CMV detection methods include serology, viral culture, polymerase chain reaction, and histologic examination [hematoxylin and eosin, immunohistochemistry (IHC), in situ hybridization (ISH)]. Until recently, ISH was performed manually. We compared automated ISH and automated IHC (Bond-max system, Leica Microsystems) in 72 cases (multiple organ systems) previously evaluated for CMV by conventional methods [hematoxylin and eosin, IHC (Dako Autostainer Plus), polymerase chain reaction, and/or viral culture]. By automated ISH, 27 cases were CMV-positive (25 positive, 2 equivocal on original diagnosis), 43 were negative (10 positive, 29 negative, 4 equivocal on original diagnosis), and 2 were equivocal (positive on original diagnosis). By automated IHC, 31 cases were CMV-positive (28 positive, 3 equivocal on original diagnosis), 39 were negative (7 positive, 29 negative, 3 equivocal on original diagnosis), and 2 were equivocal (positive on original diagnosis). Using original CMV diagnosis as gold standard, automated ISH and automated IHC had sensitivities of 67.6% and 75.7%, respectively (P value=0.25), and both had specificities of 100%. Combined automated ISH and IHC had sensitivity of 75.7% and specificity of 100%. Positive predictive values for automated ISH, automated IHC, and combination of ISH and IHC were 92.6%, 90.3%, and 90.3%, respectively. Negative predictive values were 67.4%, 74.4%, and 76.3%, respectively. We recommend either automated ISH or IHC for CMV detection in formalin-fixed, paraffin-embedded tissues. Although with moderate sensitivities, these methods have high specificities and positive predictive values, permit rapid turnover, require only set-up time, and result in strong stain intensity with minimal background.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521278     DOI: 10.1097/PAI.0b013e318185d1b5

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  6 in total

1.  Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.

Authors:  Olga Speck; Weihua Tang; Douglas R Morgan; Pei Fen Kuan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Margaret L Gulley
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-10

2.  De-novo CMV infection manifesting as interstitial nephritis in a high-risk kidney recipient with concurrent urologic complications: lessons for the clinical nephrologist.

Authors:  Alcino Gama; Sook Park; Carla LaShannon Ellis
Journal:  J Nephrol       Date:  2022-06-24       Impact factor: 4.393

3.  Epstein-Barr virus microRNAs and lung cancer.

Authors:  J Koshiol; M L Gulley; Y Zhao; M Rubagotti; F M Marincola; M Rotunno; W Tang; A W Bergen; P A Bertazzi; D Roy; A C Pesatori; I Linnoila; D Dittmer; A M Goldstein; N E Caporaso; L M McShane; E Wang; M T Landi
Journal:  Br J Cancer       Date:  2011-06-07       Impact factor: 7.640

4.  Chronic Prosopis glandulosa treatment blunts neutrophil infiltration and enhances muscle repair after contusion injury.

Authors:  Cindy George; Carine Smith; Ashwin W Isaacs; Barbara Huisamen
Journal:  Nutrients       Date:  2015-01-23       Impact factor: 5.717

Review 5.  Immunohistochemical diagnosis of human infectious diseases: a review.

Authors:  Hamadou Oumarou Hama; Gérard Aboudharam; Rémi Barbieri; Hubert Lepidi; Michel Drancourt
Journal:  Diagn Pathol       Date:  2022-01-30       Impact factor: 2.644

6.  Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile.

Authors:  Weihua Tang; Douglas R Morgan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Kennichi Kakudo; Pei Fen Kuan; Natalie Banet; Hind Muallem; Kimberly Woodward; Olga Speck; Margaret L Gulley
Journal:  Infect Agent Cancer       Date:  2012-08-28       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.